title: Targeted molecular therapy for preventing heart failure and sudden cardiac death. 28 September 2010, New York, NY, USA.
abstract: The targeted molecular therapy for preventing heart failure and sudden cardiac death discussion session, organized by the Biochemical Pharmacology Discussion Group of the New York Academy of Sciences and held in New York, included topics covering new research developments in the field of heart failure. This conference report highlights selected presentations on GPCRs for heart failure, calcium and heart function, and mitochondrial targets in heart failure. A summary of the panel discussion is also provided.
authors.affiliation: Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA. martin.schwarz@mssm.edu
authors.forename: Martin
authors.initials: M
authors.lastname: Schwarz
mesh_terms: D000818:Animals; D020013:Calcium Signaling / Q000187:drug effects; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D006333:Heart Failure / Q000378:metabolism* / Q000517:prevention & control*; D006801:Humans; D008929:Mitochondria, Heart / Q000187:drug effects / Q000378:metabolism; D058990:Molecular Targeted Therapy; D043562:Receptors, G-Protein-Coupled / Q000819:agonists / Q000037:antagonists & inhibitors
chemical_list: D043562:Receptors, G-Protein-Coupled